X
Have any questions?
March 27, 2019 – Hubrecht Organoid Technology (HUB) and JSR Corporation, the parent company, of Crown Bioscience, entered into a strategic partnership to provide preclinical oncology drug development and validation services using HUB Organoid Technology. As part of the agreement CrownBio, a wholly–owned subsidiary of JSR Corporation will expand its European presence by opening a new organoid–focused operational site in Utrecht, Netherlands.